Advertisement

Polygenic Risk Scores in Clinical Care

  • Emily R. Soper
    Affiliations
    Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1041, New York, NY 10029, USA

    Division of Genomic Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
    Search for articles by this author
  • Noura S. Abul-Husn
    Correspondence
    Corresponding author.
    Affiliations
    Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1041, New York, NY 10029, USA

    Division of Genomic Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
    Search for articles by this author
Published:September 28, 2022DOI:https://doi.org/10.1016/j.yamp.2022.07.001

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Molecular Pathology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Visscher P.M.
        • Wray N.R.
        • Zhang Q.
        • et al.
        10 Years of GWAS Discovery: Biology, Function, and Translation.
        Am J Hum Genet. 2017; 101: 5-22
        • Uffelmann E.
        • Huang Q.Q.
        • Munung N.S.
        • et al.
        Genome-wide association studies.
        Nat Rev Methods Primers. 2021; 1: 1-21
        • Burdett T.
        • Hastings E.
        • Welter D.
        SPOT, EMBL-EBI, NHGRI. GWAS Catalog.
        (Available at:) (Accessed March 30, 2022)
        • Khera A.V.
        • Chaffin M.
        • Aragam K.G.
        • et al.
        Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations.
        Nat Genet. 2018; 50: 1219-1224
        • Chatterjee N.
        • Shi J.
        • García-Closas M.
        Developing and evaluating polygenic risk prediction models for stratified disease prevention.
        Nat Rev Genet. 2016; 17: 392-406
        • Torkamani A.
        • Wineinger N.E.
        • Topol E.J.
        The personal and clinical utility of polygenic risk scores.
        Nat Rev Genet. 2018; 19: 581-590
        • Ge T.
        • Chen C.Y.
        • Ni Y.
        • et al.
        Polygenic prediction via Bayesian regression and continuous shrinkage priors.
        Nat Commun. 2019; 10: 1776https://doi.org/10.1038/s41467-019-09718-5
        • Choi S.W.
        • O’Reilly P.F.
        PRSice-2: Polygenic Risk Score software for biobank-scale data.
        Gigascience. 2019; 8https://doi.org/10.1093/gigascience/giz082
        • Vilhjálmsson B.J.
        • Yang J.
        • Finucane H.K.
        • et al.
        Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores.
        Am J Hum Genet. 2015; 97: 576-592https://doi.org/10.1016/j.ajhg.2015.09.001
        • Fatumo S.
        • Chikowore T.
        • Choudhury A.
        • et al.
        A roadmap to increase diversity in genomic studies.
        Nat Med. 2022; 28: 243-250https://doi.org/10.1038/s41591-021-01672-4
        • Martin A.R.
        • Kanai M.
        • Kamatani Y.
        • et al.
        Publisher Correction: Clinical use of current polygenic risk scores may exacerbate health disparities.
        Nat Genet. 2021; 53: 763https://doi.org/10.1038/s41588-021-00797-z
        • Elliott J.
        • Bodinier B.
        • Bond T.A.
        • et al.
        Predictive Accuracy of a Polygenic Risk Score–Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease.
        JAMA. 2020; 323: 636https://doi.org/10.1001/jama.2019.22241
        • Inouye M.
        • Abraham G.
        • Nelson C.P.
        • et al.
        Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention.
        J Am Coll Cardiol. 2018; 72: 1883-1893https://doi.org/10.1016/j.jacc.2018.07.079
        • Kullo I.J.
        • Jouni H.
        • Austin E.E.
        • et al.
        Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates: Effect on Low-Density Lipoprotein Cholesterol Levels (the MI-GENES Clinical Trial).
        Circulation. 2016; 133: 1181-1188https://doi.org/10.1161/CIRCULATIONAHA.115.020109
        • Abraham G.
        • Havulinna A.S.
        • Bhalala O.G.
        • et al.
        Genomic prediction of coronary heart disease.
        Eur Heart J. 2016; 37: 3267-3278https://doi.org/10.1093/eurheartj/ehw450
        • Kapoor P.M.
        • Mavaddat N.
        • Choudhury P.P.
        • et al.
        Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.
        J Natl Cancer Inst. 2021; 113: 329-337https://doi.org/10.1093/jnci/djaa056
        • Kuchenbaecker K.B.
        • McGuffog L.
        • Barrowdale D.
        • et al.
        Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.
        J Natl Cancer Inst. 2017; 109https://doi.org/10.1093/jnci/djw302
        • Mavaddat N.
        • Michailidou K.
        • Dennis J.
        • et al.
        Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
        Am J Hum Genet. 2019; 104: 21-34https://doi.org/10.1016/j.ajhg.2018.11.002
        • Zhang X.
        • Rice M.
        • Tworoger S.S.
        • et al.
        Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
        Plos Med. 2018; 15: e1002644https://doi.org/10.1371/journal.pmed.1002644
        • Lakeman I.M.M.
        • Hilbers F.S.
        • Rodríguez-Girondo M.
        • et al.
        Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non- breast cancer families.
        J Med Genet. 2019; 56: 581-589https://doi.org/10.1136/jmedgenet-2019-106072
        • Fahed A.C.
        • Wang M.
        • Homburger J.R.
        • et al.
        Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions.
        Nat Commun. 2020; 11: 3635https://doi.org/10.1038/s41467-020-17374-3
        • Kumuthini J.
        • Zick B.
        • Balasopoulou A.
        • et al.
        The clinical utility of polygenic risk scores in genomic medicine practices: a systematic review.
        Hum Genet Published Online. 2022; https://doi.org/10.1007/s00439-022-02452-x
        • Wand H.
        • Knowles J.W.
        • Clarke S.L.
        The need for polygenic score reporting standards in evidence-based practice: lipid genetics use case.
        Curr Opin Lipidol. 2021; 32: 89-95https://doi.org/10.1097/MOL.0000000000000733
        • Wand H.
        • Lambert S.A.
        • Tamburro C.
        • et al.
        Improving reporting standards for polygenic scores in risk prediction studies.
        Nature. 2021; 591: 211-219https://doi.org/10.1038/s41586-021-03243-6
        • Hao L.
        • Kraft P.
        • Berriz G.F.
        • et al.
        Development of a clinical polygenic risk score assay and reporting workflow.
        Nat Med. 2022; (Published online)https://doi.org/10.1038/s41591-022-01767-6
        • Lee A.
        • Mavaddat N.
        • Wilcox A.N.
        • et al.
        BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.
        Genet Med. 2019; 21: 1708-1718https://doi.org/10.1038/s41436-018-0406-9
        • Carver T.
        • Hartley S.
        • Lee A.
        • et al.
        CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants.
        Cancer Epidemiol Biomarkers Prev. 2021; 30: 469-473https://doi.org/10.1158/1055-9965.EPI-20-1319
      1. RiskScore. Myriad MyRisk.
        (Published February 19, 2022. Available at:) (Accessed March 31, 2022)
      2. How 23andMe predicted my likelihood of developing the “disease of kings.” 23andMe Blog.
        (Published July 14, 2021. Available at:) (Accessed March 22, 2022)
      3. welcome to eMerge > Collaborate.
        (Available at:) (Accessed April 17, 2022)
        • Lewis A.C.F.
        • Green R.C.
        • Vassy J.L.
        Polygenic risk scores in the clinic: Translating risk into action.
        HGG Adv. 2021; 2: 100047https://doi.org/10.1016/j.xhgg.2021.100047
      4. ACS Breast Cancer Screening Guidelines.
        (Available at:) (Accessed May 5, 2022)
        • Brockman D.G.
        • Petronio L.
        • Dron J.S.
        • et al.
        Design and user experience testing of a polygenic score report: a qualitative study of prospective users.
        BMC Med Genomics. 2021; 14: 238https://doi.org/10.1186/s12920-021-01056-0
        • van der Bles A.M.
        • van der Linden S.
        • Freeman A.L.J.
        • et al.
        The effects of communicating uncertainty on public trust in facts and numbers.
        Proc Natl Acad Sci U S A. 2020; 117: 7672-7683https://doi.org/10.1073/pnas.1913678117
        • Polygenic Risk Score Task Force of the International Common Disease Alliance
        Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps.
        Nat Med. 2021; 27: 1876-1884https://doi.org/10.1038/s41591-021-01549-6
        • Brown S.A.N.
        • Jouni H.
        • Marroush T.S.
        • et al.
        Effect of Disclosing Genetic Risk for Coronary Heart Disease on Information Seeking and Sharing: The MI-GENES Study (Myocardial Infarction Genes).
        Circ Cardiovasc Genet. 2017; 10https://doi.org/10.1161/CIRCGENETICS.116.001613
        • Widén E.
        • Junna N.
        • Ruotsalainen S.
        • et al.
        Communicating polygenic and nongenetic risk for atherosclerotic cardiovascular disease - An observational follow-up study.
        bioRxiv. 2020; https://doi.org/10.1101/2020.09.18.20197137
        • Tischkowitz M.
        • Balmaña J.
        • Foulkes W.D.
        • et al.
        Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
        Genet Med. 2021; 23: 1416-1423
        • Lewis A.C.F.
        • Green R.C.
        Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues.
        Genome Med. 2021; 13: 14